Summary: New research reveals a direct and surprising route by which alcohol alters the brain: metabolites produced when the body breaks down alcohol travel into the brain and directly change the way genes are regulated. These epigenetic modifications are detectable across multiple brain regions after prolonged exposure, with the ventral hippocampus—an area central to emotion and motivation—showing especially strong sensitivity. The findings suggest alcohol can leave lasting regulatory marks on the genome that may help drive addictive behavior.
Key Facts
- The metabolite bridge: Alcohol’s breakdown products move into the brain and interact with chromatin and other gene-regulatory machinery, directly influencing which genes are turned on or off.
- Widespread impact with repeated use: While a single exposure affects specific regions such as the hippocampus, repeated or chronic exposure spreads these epigenetic changes across all examined brain areas.
- Ventral hippocampus sensitivity: The ventral hippocampus—important for emotional processing and motivated behaviors—was especially responsive to the number of alcohol exposures, which may explain strong mood and motivation changes in chronic drinkers.
- Strong short-term effects: Some gene programs were more dramatically altered after acute exposure than after long-term use, indicating the brain mounts rapid molecular responses that can be potent from the first exposures.
Source: SfN
Erica Periandri and Gabor Egervari of Washington University in St. Louis led a study examining how alcohol exposure in male mice alters gene expression and the epigenetic mechanisms that control gene activity.
Egervari summarizes their earlier discovery: “We recently discovered that metabolites from alcohol breakdown directly regulate genes in the hippocampus after a single exposure. This direct pathway was previously unknown, and we wanted to determine whether the same mechanisms operate in other brain regions and following repeated alcohol exposure.”
Published in eNeuro, the study mapped genome-wide epigenetic and transcriptomic responses to ethanol across multiple brain regions and compared outcomes after acute versus chronic exposure in male C57BL/6J mice. The team found that alcohol-derived acetate contributes to histone acetylation, a form of chromatin modification, in response to both single and repeated exposures, with broader and more robust effects following chronic exposure.
Chromatin and transcriptomic responses varied substantially by brain region. In several areas, acute exposure produced more pronounced dysregulation of gene and transcript expression than chronic exposure. The ventral hippocampus showed particularly strong, exposure-dependent transcriptional changes, highlighting a region-specific vulnerability that aligns with its role in emotion and motivated behavior.
Overall, these results indicate that the extent of alcohol exposure—single versus repeated—determines which genes and regulatory mechanisms are affected in specific brain regions. By identifying the molecular marks left by ethanol exposure, the work creates candidate targets for developing treatments aimed at reversing or mitigating the epigenetic changes associated with alcohol use disorder.
The authors note a limitation: this study examined only male mice, so sex differences were not assessed. Nevertheless, the epigenetic markers and transcriptomic programs identified here may inform future therapeutic strategies for alcohol use disorder.
Key Questions Answered:
A: The study shows that a single alcohol exposure allows metabolites to begin regulating gene activity in the hippocampus. This is not a permanent DNA mutation but an epigenetic reprogramming—changes in how genes are used. Repeated drinking can extend these regulatory changes to additional brain regions.
A: The ventral hippocampus governs emotional responses and motivated behaviors. Because it reacts strongly to alcohol’s impact on gene regulation, changes there could underlie mood disturbances and the persistent craving and behavioral shifts seen in alcohol use disorder.
A: Reversibility remains a central question for future research. By pinpointing the specific epigenetic marks alcohol leaves, scientists aim to develop interventions that could reverse or compensate for these changes and help restore healthy gene regulation.
Editorial Notes:
- This piece was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context was provided by staff to clarify implications and limitations.
About this addiction and genetics research news
Author: SfN Media
Source: SfN
Contact: SfN Media – SfN
Image: The image is credited to Neuroscience News
Original Research: Closed access.
“Epigenetic and Transcriptomic Impacts of Ethanol Vary by Brain Region and Extent of Exposure” by Erica M. Periandri, Kala M. Dodson, Mariana Lopes, Francisca N. de Luna Vitorino, Anjola Ola, Joanna M. Gongora, Benjamin A. Garcia, Karl M. Glastad and Gabor Egervari. eNeuro
DOI: 10.1523/ENEURO.0484-25.2026
Abstract
Epigenetic and Transcriptomic Impacts of Ethanol Vary by Brain Region and Extent of Exposure
Epigenetic and transcriptional mechanisms are central contributors to alcohol use disorder (AUD). To design new pharmacotherapies, researchers need a clearer map of the specific genes, transcripts, and chromatin marks that ethanol influences.
This study systematically examined genome-wide epigenetic and transcriptomic effects of ethanol across brain regions implicated in AUD, comparing outcomes after acute versus chronic exposure in male C57BL/6J mice.
The authors show that alcohol-derived acetate promotes histone acetylation in the brain after both single and repeated exposures, with repeated exposure producing broader and more robust chromatin changes. Chromatin and transcriptomic changes were largely brain-region specific, and in several regions acute exposure produced more pronounced dysregulation of genes and transcripts than chronic exposure.
The transcriptional consequences of ethanol depended on the exposure paradigm in certain regions, most prominently in the ventral hippocampus. Overall, these results clarify and compare key epigenetic and transcriptomic outcomes linked to acute and chronic ethanol exposure, providing a foundation to guide future therapeutic development.